Cargando…
Diacerein treatment prevents colitis-associated cancer in mice
BACKGROUND: Inflammation is a well-established enabling factor for cancer development and provides a framework for the high prevalence of colon cancer in inflammatory bowel disease. In accordance, chronic inflammation has recently been implicated in the development of cancer stem cells (CSCs). Howev...
Autores principales: | Paulino, Daiane S M, Mendes, Maria Carolina S, Camargo, Juliana A, Brambilla, Sandra R, Wood Dos Santos, Tanila, Ribeiro, Marcelo L, Carvalheira, José Barreto Campello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522546/ https://www.ncbi.nlm.nih.gov/pubmed/33033695 http://dx.doi.org/10.5306/wjco.v11.i9.732 |
Ejemplares similares
-
Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice
por: Mendes, Maria Carolina S, et al.
Publicado: (2018) -
VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice
por: Wang, Chun-Sai-Er, et al.
Publicado: (2018) -
Mucosal healing progression after acute colitis in mice
por: Vidal-Lletjós, Sandra, et al.
Publicado: (2019) -
Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice
por: Liu, Zhao-Xiu, et al.
Publicado: (2022) -
Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial
por: Tres, Glaucia S., et al.
Publicado: (2018)